Antimicrobial resistance (AMR) is a high priority across countries as it increases morbidity,
mortality and costs. Concerns with AMR have resulted in multiple initiatives internationally …

Background Even though the lives of millions have been saved in the past decades, the
mortality rate in patients with drug-resistant tuberculosis is still high. Different factors are …

Objective To assess poor treatment outcomes and their predictors among drug-resistant
tuberculosis patients treated in Ethiopia. Methods Data were searched from both electronic …

Abstract Background The World Health Organization (WHO) End TB strategy aims to reduce
mortality due to tuberculosis (TB) to less than 5% by 2035. However, mortality due to …

Background Pre-COVID-19, individuals with tuberculosis (TB) in Nigeria were often
underdiagnosed and untreated. TB services were mostly in the public sector with only 15 …

Background Early diagnosis of tuberculosis (TB) is important to reduce transmission,
morbidity and mortality in people living with HIV (PLWH). Methods PLWH with a diagnosis of …

Background Mycobacterium tuberculosis with resistance to first line and second line anti
tuberculous drugs is a serious setback in the treatment of tuberculosis (TB). The COVID-19 …

Background Tuberculosis is the major cause of morbidity, and it is one of the top ten causes
of death globally. In Africa, the overall pooled estimate of unsuccessful tuberculosis …

Background: The emergence of drug-resistant tuberculosis (DRTB) has continued to pose a
threat to public health in sub-Saharan Africa and globally. Despite the high burden of …

BACKGROUND: Treating multidrug-resistant TB (MDR-TB) remains challenging. However,
the determinants and timing of poor outcomes during MDR-TB treatment are still poorly …